ROCKWELL MEDICAL, INC. Form DEFA14A: Additional definitive proxy soliciting materials
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2026-05-11: Form DEFA14A; Description DEFA14A; Document tm2614226d1_defa14a.htm.
- 2020-05-07: Form DEFA14A; Description DEFA14A; Document rmti-2020xannualmeetingxde.htm.
- 2019-06-10: Form DEFA14A; Description DEFA14A; Document a19-11254_2defa14a.htm.
- 2019-06-07: Form DEFA14A; Description DEFA14A; Document a19-11254_1defa14a.htm.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2026-05-11 | DEFA14A | DEFA14A | tm2614226d1_defa14a.htm | |
| 2020-05-07 | DEFA14A | DEFA14A | rmti-2020xannualmeetingxde.htm | |
| 2019-06-10 | DEFA14A | DEFA14A | a19-11254_2defa14a.htm | |
| 2019-06-07 | DEFA14A | DEFA14A | a19-11254_1defa14a.htm | |
| 2019-05-21 | DEFA14A | DEFA14A | a19-10130_1defa14a.htm | |
| 2018-06-21 | DEFA14A | DEFA14A | a18-15587_2defa14a.htm | |
| 2018-06-12 | DEFA14A | DEFA14A | a18-15219_1defa14a.htm | |
| 2018-06-07 | DEFA14A | DEFA14A | a18-14917_1defa14a.htm | |
| 2017-05-26 | DEFA14A | MAY 25, 2017 PRESS RELEASE | rockwell5-25press.htm | |
| 2017-05-22 | DEFA14A | Additional definitive proxy soliciting materials | rockwellpress.htm | |
| 2017-05-22 | DEFA14A | SHAREHOLDER LETTER | sb006rockwellpt2.htm | |
| 2017-05-18 | DEFA14A | Additional definitive proxy soliciting materials | cg934.htm | |
| 2017-05-16 | DEFA14A | Additional definitive proxy soliciting materials | cg932.htm | |
| 2017-05-11 | DEFA14A | DEFA14A | a17-12433_6defa14a.htm | |
| 2017-05-10 | DEFA14A | DEFA14A | a17-12433_3defa14a.htm | |
| 2017-05-10 | DEFA14A | Additional definitive proxy soliciting materials | cg929.htm | |
| 2017-05-10 | DEFA14A | Additional definitive proxy soliciting materials | cg926.htm | |
| 2017-05-09 | DEFA14A | Additional definitive proxy soliciting materials | cg926.htm | |
| 2017-05-09 | DEFA14A | Additional definitive proxy soliciting materials | cg927.htm | |
| 2017-05-04 | DEFA14A | DEFA14A | a17-12433_1defa14a.htm | |
| 2017-04-24 | DEFA14A | Additional definitive proxy soliciting materials | cg912.htm | |
| 2017-04-21 | DEFA14A | DEFA14A | a17-10221_6defa14a.htm | |
| 2017-04-04 | DEFA14A | 8-K | a17-10221_28k.htm | |
| 2017-03-03 | DEFA14A | 8-K | a17-7626_18k.htm | |
| 2016-05-31 | DEFA14A | DEFA14A | a16-12546_1defa14a.htm |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B |